Skip to main content

decentralized clinical trial

By Mallory Hackett | 03:14 pm | May 10, 2021
Science 37 will have an initial enterprise value of approximately $1.05 billion.   
By Dave Muoio | 10:00 am | February 24, 2021
The randomized controlled trial of the jointly-developed digital therapeutics will be conducted using Verily's Project Baseline and enroll up to 540 patients. 
By Mallory Hackett | 12:41 pm | February 16, 2021
Community by Current Health is now enrolling participants in a COVID-19 study that uses its FDA-cleared remote monitoring system.   
By Mallory Hackett | 12:49 pm | October 20, 2020
It works to more easily connect patients to trials, decrease administrative tasks, improve trial resiliency and enhance studies through the use of data and technology.
By Dave Muoio | 04:35 pm | September 17, 2020
Efficient distribution, dissipating stigma and an emphasis on decentralized trials are all working in favor of digital treatments, according to a panel of digital therapeutics executives and industry stakeholders.
By Dave Muoio | 03:24 pm | July 14, 2020
Also: Google promises not to use Fitbit data for targeted advertising; Renalytix AI details its international IPO; New food tracking app relies on machine learning.
By Dave Muoio | 04:15 pm | May 28, 2020
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.